Estradiol Patch Shortage Explained | Tampa News

Estradiol patches for menopause relief are in high demand, sparking a scramble as women switch brands or dosages to get their hands on them—despite the FDA not officially declaring a shortage. After removing a warning label, interest surged, but manufacturing these patches is complex and can’t scale quickly. Bayer predicts a temporary supply hiccup for one dose until 2027, while other makers rush to expand production with new lines and outside help. The FDA’s collaborating with six manufacturers to ramp up output, but patients may still face challenges finding these patches for now. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/1e46666716f6bab9